France: Ipsen expands oncology assets through acquisition of Epizyme
Euronext Paris listed Ipsen, a global, mid-sized biopharmaceutical company focused on oncology, rare disease and neuroscience, is acquiring Nasdaq listed Epizyme, a US-based fully...
Australia: Apiam Animal Health continues along acquisition path with The Vet Practice
ASX listed Apiam Animal Health, comprised of Australia’s leading veterinary practices, has acquired The Vet Practice, a full-service companion animal clinic located in Whittlesea,...
Sweden: Jonas Caspari Bark joins Realheart as CFO
Realheart, which is developing the world's first artificial four-chamber heart, has recruited Jonas Caspari Bark as its new CFO, replacing Andreas Hultdin. He joins...
Belgium: Aedifica raises €254.5m in private placement of shares
Brussels listed specialist healthcare real estate investor, Aedifica, has raised €254,475,000 (US$269,315,982) through a private placement to international institutional investors. The capital increase was...
Denmark: Tobii Dynavox makes third acquisition of 2022
Tobii Dynavox, a global leader in assistive technology for communication, has agreed to acquire all business activities and assets of its reselling partner ASK in...
Funding round-up: AiVF, Axbio, Aidoc, LynxCare, 3Z
Iceland: 3Z, a drug discovery company, has closed a US$2m funding round led by seasoned investors in pharmaceuticals and medical technology. The Reykjavik based company...
Germany: Lauxera Capital takes a majority stake in Matrix Requirements
Paris-based healthcare specialist investor. Lauxera Capital Partners, has invested €10m (US$10.5m) in German Medtech quality management software company Matrix Requirements. Matrix Requirements supports the...
France: All Seas Capital makes investment in French medical group SoMeD
All Seas Capital Fund I, a UK-based pan-European private capital fund providing flexible long-term financing solutions to mid-cap companies, has made an undisclosed investment...
The Netherlands: Astorg takes majority stake in Avania from Kester
Paris-based PE firm, Astorg, has acquired a majority stake in Avania, a Netherlands-based full-service global MedTech contract research organization (CRO), from UK-based Kester Capital....
Belgium: Galapagos accelerates access to next-generation cell therapies with CellPoint and AboundBio acquisitions
Mechelen-based Galapagos, a fully integrated biotechnology company focused on discovering, developing and commercializing innovative medicines, is acquiring CellPoint and AboundBio, propelling Galapagos into next-generation...
©2023 All rights reserved LaingBuisson 
